| Cash Flow | 2025-09-30 |
|---|---|
| Net income | 749,387 |
| Depreciation and amortization | 316,066 |
| Stock options expense | 58,706 |
| Restricted common stock expense | 153,776 |
| Adjustment to contingent earnout liability | 317,966 |
| Accounts receivable | -292,053 |
| Prepaid expenses and other current assets | 140,004 |
| Prepaid royalties | 79,513 |
| Accounts payable and accrued expenses | 158,728 |
| Deferred revenue | -720,046 |
| Net cash provided by operating activities | 1,107,119 |
| Purchase of property and equipment | 17,539 |
| Net cash used in investing activities | -17,539 |
| Common stock repurchase | 23,387 |
| Payment of contingent acquisition consideration - scite and fiz | 1,337,857 |
| Net cash used in financing activities | -1,361,244 |
| Effect of exchange rate changes | 115 |
| Net increase (decrease) in cash and cash equivalents | -271,549 |
| Cash and cash equivalents at beginning of period | 12,227,312 |
| Cash and cash equivalents at end of period | 11,955,763 |
Research Solutions, Inc. (RSSS)
Research Solutions, Inc. (RSSS)